Sanj K. Patel, CHAIRMAN & CEO at Kiniksa Pharmaceuticals International, plc (KNSA), sold 89,561 shares at $23.00 ($2.1M) on 2024-11-06, disclosed to the SEC on 2024-11-08.
Scheduled sale ($2.1M) by CHAIRMAN & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KNSA | SELL | 2026-04-08 | $364K | — | Filing → |
| KNSA | SELL | 2025-10-22 | $20.0M | — | Filing → |
| KNSA | SELL | 2025-05-28 | $4.6M | — | Filing → |